Our study revealed that PAL alleviated PM-induced lung inflammation in mice through activation of the Nrf2-associated antioxidant pathway and inhibition of the NLRP3-associated pyroptosis pathway, providing robust evidence for its therapeutic application in inflammatory conditions and offering a novel and effective approach to treating acute lung injury-induced by PM. This evidence concerns the gene NFE2L2 and inflammation.